Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Arch Therapeutics, Inc. | tv506489_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Arch Therapeutics, Inc. | tv506489_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Arch Therapeutics, Inc. | tv506489_ex31-1.htm |
| 10-K - FORM 10-K - Arch Therapeutics, Inc. | tv506489_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors
Arch Therapeutics, Inc. and Subsidiary
Framingham, MA
We hereby consent to the incorporation by reference in the Registration Statements (Nos. 333-194745; 333-206873; and 333-212213) on Forms S-1, Registration Statements (Nos. 333-213878; 333-214347; 333-214349; and 333-214350) on Form S-3 and the Registration Statements (Nos. 333-193516; 333-201229; 333-207314; and 333-214429) on Forms S-8 of our report dated December 5, 2016, relating to the consolidated financial statements of Arch Therapeutics, Inc. and subsidiary, as of and for the years ending September 30, 2018 and 2017.
We also consent to the reference to us under the heading “Experts” in such Registration Statements.
| /s/ Moody, Famiglietti & Andronico, LLP | |
| Tewksbury, Massachusetts | |
| December 18, 2018 |